Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have been trying to figure out

"I thought the present litigation was because of this very subject."

It is. So if the claim was that TPL was overcharging on expenses, and under cutting the MMP price in order to cut deals on other portfolios, it begs the question WHY if that were to be fixed, would we now need a SUBSTANTIAL INCREASE in working capital? If they fixed those items, that should lead to more money available with which to fund the working capital balance. Why the need to increase that formula then?

Obviously, I hope that there are now mechanisms in place that would prevent it, but is the treatment of an alcoholic to get him into rehab, but then stock his fridge with MORE alcohol than he had access to before? Fool me once, shame on me, fool me twice.... well.... er..... won't get fooled again!

Share
New Message
Please login to post a reply